Hacker News
- Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever https://arstechnica.com/science/2021/11/dubious-56000-alzheimers-drug-spurs-largest-medicare-price-hike-ever/ 43 comments
- Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever https://arstechnica.com/science/2021/11/dubious-56000-alzheimers-drug-spurs-largest-medicare-price-hike-ever/ 42 comments technology
- Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever https://arstechnica.com/science/2021/11/dubious-56000-alzheimers-drug-spurs-largest-medicare-price-hike-ever/ 15 comments politics
Linking pages
Linked pages
- How Biogen used an FDA back channel to win Alzheimer's drug approval https://www.statnews.com/2021/06/29/biogen-fda-alzheimers-drug-approval-aduhelm-project-onyx/ 39 comments
- Controversial Alzheimer’s drug could cost US $334B—nearly half of DoD budget | Ars Technica https://arstechnica.com/science/2021/06/controversial-alzheimers-drug-could-cost-us-334b-nearly-half-of-dod-budget/ 17 comments
- FDA officials asked to step down after contentious Alzheimer’s drug approval | Ars Technica https://arstechnica.com/science/2021/06/advocacy-org-calls-for-ouster-of-fda-officials-after-alzheimers-drug-approval/ 4 comments
- A “disgraceful decision:” Researchers blast FDA for approving Alzheimer’s drug | Ars Technica https://arstechnica.com/science/2021/06/a-disgraceful-decision-researchers-blast-fda-for-approving-alzheimers-drug/ 0 comments
Related searches:
Search whole site: site:arstechnica.com
Search title: Dubious $56,000 Alzheimer’s drug spurs largest Medicare price hike ever | Ars Technica
See how to search.